Atrial fibrillation: current concepts.

Atrial fibrillation (AF) is the most common arrhythmia which is a focus of newer modalities of treatment, especially ablation techniques using innovative mapping techniques. Its incidence and prevalence increases with aging and presence of structural heart disease, the latter being less than 1% prior to age 40, rising to 8% at age 80. Concomittant morbidity and excessive mortality is related to the increased incidence of stroke and congestive heart failure. Once developed in a clinical setting, it tends to either persist or recur. Pharmacotherapy to control rate or rhythm tends to have a secondary failure, and therefore there is a growing interest in ablation techniques. The use of anticoagulation is also associated with bleeding risks and therefore the management of AF needs to be individualized in every patient. In this article, we shall be discussing clinical types of AF, etiology, the mechanism of genesis, symptoms, complications and approach to treatment in various clinical scenarios.